Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Raymond Taeyong Chung, M.D.

Co-Author

This page shows the publications co-authored by Raymond Chung and Ruslan Sadreyev.
Connection Strength

0.838
  1. Type I, II, and III interferon signatures correspond to COVID-19 disease severity. J Infect Dis. 2021 May 24.
    View in: PubMed
    Score: 0.241
  2. Type I, II, and III interferon signatures correspond to COVID-19 disease severity. medRxiv. 2021 Mar 12.
    View in: PubMed
    Score: 0.238
  3. HELZ2 Is an IFN Effector Mediating Suppression of Dengue Virus. Front Microbiol. 2017; 8:240.
    View in: PubMed
    Score: 0.179
  4. Type I, II, and III Interferon Signatures Correspond to Coronavirus Disease 2019 Severity. J Infect Dis. 2021 09 01; 224(5):777-782.
    View in: PubMed
    Score: 0.061
  5. Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver Disease. Clin Infect Dis. 2021 08 16; 73(4):621-630.
    View in: PubMed
    Score: 0.061
  6. A MicroRNA Linking Human Positive Selection and Metabolic Disorders. Cell. 2020 10 29; 183(3):684-701.e14.
    View in: PubMed
    Score: 0.058
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.